Anti-Osteoclast Therapy

Grant Details

Grantee Name:
 Dr. Varun Monga
Organization: University of Iowa

Country: USA

Project Name: Anti-Osteoclast Therapy as an Adjuvant in Treatment of Chondrosarcoma

Funding Year: 2017

Project period: 3 years

Anti-Osteoclast Therapy as an Adjuvant in Treatment of Chondrosarcoma

This is a single-arm, open-label phase Ib clinical trial. 15 patients will receive 1 dose of zoledronic acid, followed by surgery 21 days after this dose. A second dose will be given 3 weeks after the surgery and patients will be monitored thereafter for 5 years.

icon-social-share-linkedin Created with Sketch.
icon-play Created with Sketch.
icon-download Created with Sketch.